Filing Details
- Accession Number:
- 0001209191-16-135653
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-05 13:01:48
- Reporting Period:
- 2016-08-03
- Filing Date:
- 2016-08-05
- Accepted Time:
- 2016-08-05 13:01:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197023 | S Joshua Boger | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-08-03 | 6,500 | $36.30 | 274,725 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-08-03 | 3,300 | $100.09 | 271,425 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-08-03 | 3,200 | $100.74 | 268,225 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-08-03 | 30,500 | $100.55 | 92,200 | No | 4 | S | Indirect | Common Stock Held In Trust |
| Common Stock | Disposition | 2016-08-03 | 10,000 | $101.17 | 82,200 | No | 4 | S | Indirect | Common Stock Held In Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | Common Stock Held In Trust |
| No | 4 | S | Indirect | Common Stock Held In Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-08-03 | 6,500 | $0.00 | 6,500 | $36.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 151,000 | 2017-01-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,286 | Indirect | 401k |
Footnotes
- Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- The holder undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $100.09 (range $99.44 to $100.43).
- Open market sales reported on this line occurred at a weighted average price of $100.74 (range $100.47 to $101.37).
- Open market sales reported on this line occurred at a weighted average price of $100.55 (range $100.00 to $100.99).
- Open market sales reported on this line occurred at a weighted average price of $101.17 (range $101.00 to $101.50).
- Fully vested.
Billionaire Hedge Funds
